These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8195821)

  • 1. An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis.
    Mazzini L; Testa D; Balzarini C; Mora G
    J Neurol; 1994 Feb; 241(4):223-7. PubMed ID: 8195821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of selegiline and vitamin E in the treatment of ALS: an open randomized clinical trials].
    Kwieciński H; Janik P; Jamrozik Z; Opuchlik A
    Neurol Neurochir Pol; 2001; 35(1 Suppl):101-6. PubMed ID: 11732275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selegiline is ineffective in a collaborative double-blind, placebo-controlled trial for treatment of amyotrophic lateral sclerosis.
    Lange DJ; Murphy PL; Diamond B; Appel V; Lai EC; Younger DS; Appel SH
    Arch Neurol; 1998 Jan; 55(1):93-6. PubMed ID: 9443715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the efficacy of treatment with pimozide in patients with amyotrophic lateral sclerosis. Introductory notes].
    Szczudlik A; Tomik B; Słowik A; Kasprzyk K
    Neurol Neurochir Pol; 1998; 32(4):821-9. PubMed ID: 9864711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial.
    Chiò A; Cucatto A; Terreni AA; Schiffer D
    Ital J Neurol Sci; 1998 Dec; 19(6):363-6. PubMed ID: 10935831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M; Ecker D; Horowski R; Kramer B; Riederer P; Gerlach M; Hager C; Ludolph AC; Becker G; Osterhage J; Jost WH; Schrank B; Stein C; Kostopulos P; Lubik S; Wekwerth K; Dengler R; Troeger M; Wuerz A; Hoge A; Schrader C; Schimke N; Krampfl K; Petri S; Zierz S; Eger K; Neudecker S; Traufeller K; Sievert M; Neundörfer B; Hecht M;
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history and the effects of gabapentin in amyotrophic lateral sclerosis.
    Mazzini L; Mora G; Balzarini C; Brigatti M; Pirali I; Comazzi F; Pastore E
    J Neurol Sci; 1998 Oct; 160 Suppl 1():S57-63. PubMed ID: 9851651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.
    Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S
    Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical polymorphism of amyotrophic lateral sclerosis].
    Kovrazhkina EA; Razinskaya OD; Gubsky LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):4-10. PubMed ID: 28884711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
    Pinto S; Pinto A; De Carvalho M
    Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Meininger V; Genge A; van den Berg LH; Robberecht W; Ludolph A; Chio A; Kim SH; Leigh PN; Kiernan MC; Shefner JM; Desnuelle C; Morrison KE; Petri S; Boswell D; Temple J; Mohindra R; Davies M; Bullman J; Rees P; Lavrov A;
    Lancet Neurol; 2017 Mar; 16(3):208-216. PubMed ID: 28139349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of recombinant interferon beta-1a in ALS. Italian Amyotrophic Lateral Sclerosis Study Group.
    Beghi E; Chiò A; Inghilleri M; Mazzini L; Micheli A; Mora G; Poloni M; Riva R; Serlenga L; Testa D; Tonali P
    Neurology; 2000 Jan; 54(2):469-74. PubMed ID: 10668716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.